Richard W. Nielsen

CURRENT CLINIC ADDRESS

Ear, Nose, and Throat Center
22 South 900 East
Salt Lake City, Utah 84102


MEDICAL LICENSE

State of Utah (# 156578-1205)


UNDERGRADUATE EDUCATION

1962-1966
University of Utah
Salt Lake City, Utah
B.S. Zoology


GRADUATE EDUCATION

1967-1971
Creighton University
Omaha, Nebraska
Doctor of Medicine


INTERNSHIP

San Joaquin General Hospital
Stockton, Califomia


RESIDENCY

1972-1973
San Joaquin General Hospital
Stockton, California
General Surgery

1973-1976
University of Utah Affiliated Hospital
Salt Lake City, Utah
Division of Otolaryngology


PROFESSIONAL EXPERIENCE

1978- Present
Ear, Nose, and Throat Center
Salt Lake City, Utah

Private Practice, Otolaryngology


MILITARY EXPERIENCE

1976-1978
97th General Hospital
Frankfurt, Germany
Major, US Army Medical Corps


EDITORIAL EXPERIENCE

Otolaryngology News
New York City, New York
Editor


ADMINISTRATIVE EXPERIENCE

1980- 2014
Salt Lake Regional Medical Center
Salt Lake City, Utah

Chairman, Credential Committee

1985- 2002
Salt Lake Regional Hospital
Salt Lake City, Utah
Director of Resident Training
Otolaryngology

1984-1987
Salt Lake Regional Medical Center
Salt Lake City, Utah
Chairman, Department of Surgery

1980-1982
Utah State Society, ENT
Secretary

1980-1982
Primary Children’s Medical Center
Salt Lake City, Utah
Chairman, Division of ENT

1975-1976
University of Utah Affiliated Hospitals
Salt Lake City, Utah
Division of Otolaryngology
Department of Surgery
Chief Resident


HONORS AND CERTIFICATIONS

1981
Fellow American College of Surgeons

1972
National Board of Medical Examiners

Board Certified in Otolaryngology

Army Commendation Medal as Staff Otolaryngologist


HOSPITAL PRIVILEGES

Alta View Hospital
Salt Lake City, Utah
Active Staff

LDS Hospital
Salt Lake City, Utah
Courtesy Staff

Primary Children’s Medical Center
Salt Lake City. Utah
Courtesy Staff

Salt Lake Regional Medical Center
Salt Lake City, Utah
Active Staff


PROFESSIONAL MEMBERSHIPS

American Council of Otolaryngology

American Medical Association

Utah State Medical Society

American Acadamy of Opthamology & Otolaryngology

Fellow American College of Surgeons


CONTINUING EDUCATION

Apr. 19-23, 1977: Fourteenth Annual Post-Graduate Course in Head and Neck Surgery. University of Southern California School of Medicine.

Sept. 15-21, 1977: ENT Review. University of Illinois, Chicago, Illinois

June 2-15, 1979: Temporal Bone Surgical Dissection Course. Ear Research Institute, Los Angeles, California.

May 4-8, 1980: Maxillofacial Trauma. Sacramento Society of Otolaryngology and Maxillofacial Surgery, El Macero, California.

Oct. 8-9, 1981: The ENT Laser Workshop. University of Utah, Salt Lake City, Utah.

June 6-11, 1982: Iowa Head and Neck Center Reconstructive Surgery. University of Oregon, Dept. ofENT, Portland, Oregon.

Apr. 23-29, 1984: Temporal Bone Surgical Dissection Course. House Institute Los Angeles, California.

July 25-26, 1986: Iron County Medical Society Symposium. Cedar City, Utah.

Mar. 17~18, 1987: Ear Research Institute Audiant Implant. Oklahoma City, Oklahoma.

May 16-17, 1988: Endoscopic Sinus Surgery. University of Chicago, Chicago, Illinois.

Apr. 27-28, 1989: The Credentialing Institute. Los Angeles, California.

May 6, 1989: Laser ENT Mini Course. Holy Cross Hospital, Salt Lake City, Utah.

May 23-25, 1989: Advances in Treatment of Menier’s Disease. University of Chicago, Chicago, Illinois.

Feb. 22-23, 1990: Advanced Endoscopic Sinus Surgery with Steven Shafer. University of Texas Southwest Dallas, Texas.

Feb 6-9,1991: Symposium on Advanced Concepts in Endoscopic Sinus Surgery- Faculty. Salt Lake City, Utah.

Jan. 22-26, 1992: Symposium on Advanced Functional Endoscopic Sinus Surgery- Facility. Salt Lake City, Utah.

Nov. 1-2, 1992: Current Laser concepts in Otorhinolaryngology. Houston, Texas.

June 21-28, 1992: Russian American ENT Exchange, st. Petersburg, Russia.

Feb 10-14, 1993: Symposium of Advanced Functional Endoscopic Sinus Surgery- Faculty, Salt Lake City, Utah.


PRESENTATIONS

Anemia and Skin Flap Survival. Joined in Conference of Head and Neck Surgeries San Diego, California, 1976.

Current Concepts in Micro Surgery. US Army Europe Annual Medical Surgical Conference, Garmisch, West Germany, 1978.

Loracarbefvs. Augmentin in the Treatment of Maxillary Sinusitis. Investigators Meeting on Loracarbef, San Francisco, California, June 16, 1991.

Techniques of Antral Irrigation. Cefdiner Investigators Meeting, Orlando, Florida, Apr.S, 1992.

Resection of Zenkers Diverticulum. Sierra Medical Center, El Paso, Texas, March 17, 1993.

Medical Management of Sinusitis. Sierra Medical Center, El Paso, Texas, March 17,1993.

Optimizing Medical Management of pediatric and Adult Sinusitis. Mineapolis, MN, September 23, 1993.

Sinusitis in the Adult & Pediatric Populations. Symposium on Current Concepts in Infectious Disease & Stomach Disorders, Cleveland, Ohio, October 9, 1993.

Acute Upper Respiratory Infections. The Utah Academy of Physicians Assistants, Salt Lake City, Utah, October 21, 1993.


PUBLICATIONS

“Loracarbef vs AmoxicillinlClavulanate in Bacterial Sinusitis.” Ear Nose and Throat Journal. May 1992.

“Acute Bacterial Maxillary Sinusitis: Results of US & European Comparative Therapy Trials.” The American Journal of Medicine. (SuppL 6A) June 1992.

“Anemia in Skin Flap Survival.” Archives of Otolaryngology. August 1977.

“Ceflacor vs. Amoxicillin in the Treatment of Acute, Recurrent and Chronic Sinusitis.” Archives of Family Medicine. May 1993.


PAST AND ONGOING RESEARCH

Efficacy and Safety of XXX in the Treatment of Acute Peripheral Tinnitis 2 (TACTT2). 2014. Sponsored by Auris.

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease.

2013. Sponsored by Otonomy.

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO- 201 Given As a Single Intratympanic Injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement. 2013. Sponsored by Otonomy.

Proof-of-Concept of Single Application of XXX Otic Suspension in Treatment of Acute Otitis media with Tympanostomy Tubes Compared to CIPRODEX (BID for 7 days). 2013. Sponsored by Alcon.

A 16-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety oflntranasal Administration of 100,200, and 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Bilateral Nasal Polyposis Followed by an8-Week Open-Label Extension Phase to Assess Safety. 2013. Sponsored by Optinose.

A 12-Month Open-Label Multicenter Study Evaluating the Safety oflntranasal Administion of µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis

With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A 3-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic

Sinusitis With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing XXX Sinus Implant Used in post-Sinus Surgery Patients with Recurrent Sinus Obstruction. 2013. Sponsored by Intersect ENT.

A Clinical Evaluation of the Mechanical Contribution of XXX Sinus Implant in Improving Sinus Patency and Symptoms When Used in post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction-Ethmoid Sinus Patency (ESP) Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of the Steroid-Eluting S8 Sinus Implant Used Following Endoscopic Sinus Surgery (ESS) in Patients with Chronic Sinusitis-XXX Surgical Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX in Improving Sinus Patency and Symptoms When Used in post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX Used Following Endoscopic Sinus Surgery in Patients with Chronic Sinusitis. 2012. Sponsored by Intersect ENT.

A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of XXX plus XXX compared to XXX and to :xxx in the Treatment of Acute Otitis Media with

Tympanostomy Tubes (AOMT) in Pediatric Patients. 2012. Sponsored by Laboratorios SAL VA T, S.A.

Safety and Efficacy Evaluation of Topical XXX Otic Suspension in the Treatment of Acute Otitis Extema. 2012. Sponsored by Alcon Research, Ltd.

Topical Treatment of Acute Otitis Media through Tympaostomy Tubes (AOMT) and its

Effect on Microbial Flora Distal to the Site oflnfection. 2011. Alcon Research

Safety and Efficacy Evaluation of Topical XXX in the Treatment of Acute Otitis Media with

Otorrhea in Tympanostomy Tubes. 2010. Sponsored by Alcon Research Ltd.

Natural History Study ofIncidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. 2010. Sponsored by Alcon Research Ltd.

A Clinical Evaluation of XXX when Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis. 2009. Sponsored by Intersect ENT.

Safety of XXX in Patients with Perennial Allergic Rhinitis. 2009. Alcon Research, Ltd.

A Clinical Evaluation of XXX When Used Following Functional Endoscopic Sinus Surgery in Patients with Chronic Sinusitis. 2009. Sponsored by Sinexus Inc.

A Clinical Evaluation of XXX When Used Following Functional Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis. 2008. Sponsored by Sinexus Inc.

Safety and Efficacy of XXX in the Treatment of Acute Otitis Extema. 2008. Sponsored by Alcon Research Ltd.

Safety and Efficacy of XXX in the Treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes. 2006. Sponsored by Alcon Research Ltd.

xxx in the Treatment of Acute Otits Media Due to Highly Penicillin Resistant Streptococcus Pneumoniae in Children with Tympanostomy Tubes. 2002. Sponsored by Daiichi through Concepts in Pharmaceutical Research.

xxx for 4 Days vs. XXX for 6 Days for the Treatment of Acute Bacterial Sinusitis. 2002. Sponsored by Pfizer through PPD Development.

XXX for 7 days in the Treatment of Acute Bacterial Sinusitis. 2001. Sponsored by Bayer Corporation through Paragon Biomedical.

xxx in the Treatment of Acute Bacerial Sinusitis. 2000. Sponsored by Abbott Laboratories through The Phoenix.

xxx Compared to XXX for the Treatment of Acute Otitis Externa (AOE). 1999. Sponsored by Alcon Laboratories through Target Research.

xxx in the Treatment of Acute Bacterial Sinusitis in Patients Undergoing Sinus Aspirate. 1999. Sponsored by Bristol-Myers Squibb.

xxx in the Treatment of Acute Bacterial Sinusitis in Adults. 1999. Sponsored by SmithKline Beecham.

xxx vs. XXX vs. XXX for the Treatment of Acute Otitis Externa. 1998. Sponsored by Alcon Laboratories through ACER.

XXX in the Treatment of Acute Maxillary Sinusitis in Adults. 1998. Sponsored by Abbott Laboratories through IBAH

xxx , Various Doses, vs. XXX in the Treatment of Acute Maxillary Sinusitis in Adults. 1998. Sponsored by Hoechst Marion Roussel through lBAH

xxx Open Label, in the Treatment of Acute, Uncomplicated Bacterial Sinusitis, in Patients Undergoing Sinus Aspirate. 1997. Sponsored by Bristol-Myers Squibb through lBAH.

xxx and XXX in the Treatment of Patients with Streptococcal Pharyngitis. 1997. Sponsored by Tap Holdings through Scirex.

:xxx in the Treatment of Patients with Acute Bacterial Maxillary Sinusitis, 1996. Sponsored by Bayer Corporation through The Phoenix.

xxx vs. Control in the Treatment of Patients with Otorrhea Prophylactic. 1996. Sponsored by Daiichi Pharmaceutical,

xxx vs. XXX in the Treatment of Patients with Acute Maxillary Sinusitis. 1996. Sponsored by Orho-McNeil.

XXX in the Treatment of Patients with Acute Maxillary Sinusitis Undergoing Sinus Aspirate.

1996. Sponsored by Rhone-Poulenc Rorer.

XXX in the Treatment of purulent Otorrhea in Adolescent and Adult Patients with Chronic Perforation of Tympanic Membranes. 1995. Sponsored by Daiichi through The Phoenix.

xxx in the Treatment of Acute Otorrhea in Pediatric Patients with Tympanostomy Tubes. 1995. Sponsored by Daiichi through The Phoenix.

xxx vs. XXX in the Treatment of Acute Otorrhea inPediatric Patients with Tympanoplasty Tubes. 1995. Sponsored by Daiichi through The Phoenix.

XXX, Varied Dosing Regimens, in Treatment of Acute Sinusitis. 1994. Sponsored by Bristol-Myers Squibb.

xxx vs. XXX in the Treatment of Pediatric Patients with Acute Otitis Media, Protocol #066-186-25E. 1994. Sponsored by Pfizer Pharmaceutical.

XXX vs. XXX for the Treatment of Acute Maxillary Sinusitis. 1994. Sponsored by Pfizer through PPD Pharmaco.

xxx VS. XXX in the Treatment of Patients with Acute Maxillary Sinusitis Undergoing Sinus Aspirate. 1992. Sponsored by Bayer Corporation.

XXX, Advanced Formula, in a sinus Fluid PK Study. 1989. Sponsored by Eli Lilly and Company.

XXx vs. xxx in the Treatment of Patients with Otitis Media. 1989. Sponsored by Eli Lilly and Company.

xxx vs. XXX in the Treatment of Patients with Acute Maxillary Sinusitis. 1988. Sponsored by Eli and Company.

xxx vs. XXX in the Treatment of Acute Maxillary Sinusitis. 1986. Sponsored by Eli and Company.

Patient Portal

OFFICE HOURS:
8:00 am to 5:00 pm
MONDAY-FRIDAY